Cellectis (CLLS) Inventory Average (2016 - 2025)
Cellectis (CLLS) posted Inventory Average of -$89.0 million for Q3 2025, down 75.55% on a QoQ basis from -$50.7 million in Q2 2025, and down 625.32% year-over-year from $16.9 million in Q3 2024.
Cellectis (CLLS) has 9 years of Inventory Average data on file, last reported at -$89.0 million in Q3 2025.
- In Q3 2025, Inventory Average fell 625.32% year-over-year to -$89.0 million; the TTM figure through Sep 2025 stood at -$89.0 million (down 625.32% YoY), while the FY2020 annual figure was $2.2 million, up 41.77% from the prior year.
- Inventory Average retreated to -$89.0 million in Q3 2025, from -$50.7 million in the prior quarter.
- Across five years, Inventory Average topped out at $16.9 million in Q3 2024 and bottomed at -$89.0 million in Q3 2025.
- A 4-year average of -$28.8 million and a median of -$14.6 million in 2021 frame the typical range for Inventory Average.
- Annual changes were most pronounced in 2021 — Inventory Average jumped 36.58% — and 2025, when it plunged 3684.65%.
- Year by year, Inventory Average stood at $2.1 million in 2021, then slumped by 3360.41% to -$67.5 million in 2022, then soared by 125.08% to $16.9 million in 2024, then sank by 625.32% to -$89.0 million in 2025.
- The last three Inventory Average figures came in at -$89.0 million (Q3 2025), -$50.7 million (Q2 2025), and $16.9 million (Q3 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 30.59 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 1.73 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 3.15 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 83.37 Mn |
| 10 | Cellectis | 20.83 Bn | 20.62 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -88.96 Mn |
| Jun 30, 2025 | -50.68 Mn |
| Sep 30, 2024 | 16.93 Mn |
| Jun 30, 2024 | -1.34 Mn |
| Sep 30, 2022 | -67.52 Mn |
| Jun 30, 2022 | -41.16 Mn |
| Sep 30, 2021 | 5.60 Mn |
| Jun 30, 2021 | 7.42 Mn |
| Mar 31, 2021 | 3.46 Mn |
| Dec 31, 2020 | -40.87 Mn |
| Sep 30, 2020 | -79.94 Mn |
| Jun 30, 2020 | -62.77 Mn |
| Mar 31, 2020 | -23.05 Mn |
| Dec 31, 2019 | 3.12 Mn |
| Sep 30, 2019 | -24.91 Mn |
| Jun 30, 2019 | -26.05 Mn |
| Mar 31, 2019 | 664,500.00 |
| Dec 31, 2018 | 249,000.00 |
| Sep 30, 2018 | 227,000.00 |
| Jun 30, 2018 | 217,000.00 |
| Mar 31, 2018 | 226,500.00 |
| Dec 31, 2017 | 187,500.00 |
| Sep 30, 2017 | -15.01 Bn |
| Jun 30, 2017 | -24.42 Bn |
| Mar 31, 2017 | -9.40 Bn |
| Dec 31, 2016 | -67.27 Bn |
| Sep 30, 2016 | -138.72 Bn |
| Jun 30, 2016 | -133.38 Bn |